Revisit the classic Star Trek series and a few of its characters that, unfortunately, haven't exactly aged like good Saurian ...

The published data showed that the combination of avutometinib plus defactinib demonstrated a confirmed overall response rate of 31% in all patients with recurrent low-grade serous ovarian cancer ...